Exclusive with Prof Joao Pedro de Magalhaes: talking AI, indication expansion and animal models.
“Will you still need me, will you still feed me, when...
The presence of a “metabolic clock” that regulates aging involves the accumulation of metabolic alterations and a decline in metabolic homeostasis and biological fitness.
An...
Talking Longevity, indication expansion, killifish and regeneration with Dr Aric Rogers from the MDI Biological Laboratory.
Nestled on the picturesque coastline of Maine, USA, the...
Anecdotal results for dietary supplement show significant improvements in biological age and major reductions in key blood biomarkers.
In our recent interview with leading Longevity...
“We're not trying to make billionaires live longer, we're trying to make everybody live longer.”
When it comes to thought leaders in the Longevity sector,...
While Phase 3 trial of RTB101 for respiratory illness did not meet primary endpoint, company presses-on with Parkinson’s trial for TORC1 inhibitor: Results expected...
AI start-up NetraMark targets $3 million seed round while identifying that an exciting repurposing candidate has potential for indication expansion into Longevity.
“I won’t tell you...
Partnership sees AI platform expanded into drug repurposing and discovery.
Canadian AI technology firm NetraMark yesterday announced the extension of its NetraPharma collaboration agreement with...
Groundbreaking TAME trial, which directly targets aging as an endpoint, finally begins this November, reveals lead clinician Dr Nir Barzilai.
After closing the final $40m...
Report finds that anti-diabetic drug metformin could make exercise less effective at improving health but aging researchers remain upbeat.
Metformin has been, for a long...
Aspirin could reduce healthcare spending by nearly $700 billion in the US alone – and it's already in mass-production.
Acetylsalicylic acid, orginally extracted from willow...
We speak with GRG's Johnny Adams, a key contributor to the Longevity2020 online conference, about his quest for more healthy years.
One of the speakers at this month’s...
We speak with a key contributor to the Longevity2020 online conference about biological aging.
UK start-up AgeCurve is focused on the measurement of aging and...
Longevity researcher proposes clinical trials for low-dose rapamycin (and other geroprotectors) to protect the elderly from COVID-19.
The UK's Biogerontology Research Foundation today announced the...
Soaking up Longevity - a Stanford University team has rejuvenated aging human cells with a novel protein "bath" and formed a spinout.
Researchers at Stanford...
